Image 4_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Table 7_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Table 4_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Table 5_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Table 2_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Image 3_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Image 5_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Table 3_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Table 9_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Table 8_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.xlsx حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Image 2_Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC.jpeg حسب Xiyu Song (14914467)

"…The overall percentage of activated MCs in ccRCC tissues did not change significantly but shifted toward a more activated subpopulation (VEGFA⁺ MCs), with a concomitant decrease in proliferative MCs (TNF⁺ MCs) and resting MCs. …"

Data Sheet 1_Unveiling the effects of land use and intra-seasonal variation on bee and plant diversity and their ecological interactions in vegetation surrounding coffee plantation... حسب Quebin Bosbely Casiá-Ajché (14234267)

"…Additionally, we observed higher visit frequency and richness of bees and plant generality during the second period of the rainy season (July to October), leading to more robust bee–plant interaction networks in the same period. …"

Table 1_Association between estimated glucose disposal rate and the risk of atherosclerotic cardiovascular disease: insight from cross-sectional and retrospective cohort studies.do... حسب Zixuan Wang (35190)

"…</p>Results<p>A significant negative linear association between eGDR and ASCVD risk was observed in our study. …"

Image1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

"…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"

Image2_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

"…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"

Image8_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

"…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"

Image5_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

"…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"

Image6_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

"…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"

Image3_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

"…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"

DataSheet1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.pdf حسب Xiang Xiao (44417)

"…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"